$35M Investment Boosts Boston Oncology Arabia’s Growth and Innovation
TLDR: Boston Oncology Arabia, a bio-generic drugs manufacturing company in Saudi Arabia, received a $35M investment from TVM Capital. The investment will be used to enhance the company’s move into full formulation